Skip to content
Search

Latest Stories

Submit Guest Post

India hopes for G20 to develop amicable resolutions on geopolitical issues

India, now president of the G20, has taken a mostly neutral stance, generally declining to blame Russia and urging a diplomatic solution

India hopes for G20 to develop amicable resolutions on geopolitical issues

The G20 summit negotiator for India Amitabh Kant expressed the nation's intention to diplomatically persuade G20 member countries towards resolving geopolitical challenges.

In response to a question concerning the Russia-Ukraine war, Kant said on Friday (25) that India seeks amicable solutions. The ongoing conflict, which began in February last year, has deeply impacted global diplomacy.


India, now president of the G20, has taken a mostly neutral stance, generally declining to blame Russia and urging a diplomatic solution.

Speaking at a Business 20 (B20) summit in New Delhi, Kant said the group stood for growth but war created "a huge implication in terms of economics", by bringing challenges regarding food, fuel, and fertiliser.

"The war is not our creation," Kant said. "Our challenge is to put developmental issues right in the forefront."

The G20 summit is set to take place next month.

During the two-day event, India hopes to forge agreement among members on matters ranging from reforms of multilateral banks to developing a global approach on cryptocurrencies.

(Reuters)

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

cervical -cancer-hpv-vaccine

HPV is the most common sexually transmitted infection

Photo for representation: iStock

HPV vaccine reduces cervical cancer deaths to near zero, study finds

Highlights

  • No women aged 20–24 died from cervical cancer in England between 2020 and 2024
  • HPV vaccination is estimated to have prevented nearly 200 deaths among young women
  • Study provides first direct evidence linking HPV vaccination to reduced cervical cancer mortality
  • Vaccine introduced for girls in 2008 in the UK
  • Researchers say higher vaccination uptake is needed to protect future gains

THE HPV vaccine for cervical cancer has reduced the risk of dying from the disease before the age of 30 in England to almost zero, the first study of its kind showed on Thursday (18).

Keep ReadingShow less